Quick Answer
SANUWAVE Health, Inc. reported Cash and Equivalents of $11.96 million for fiscal year 2025.
SANUWAVE Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $11.96M | +16.8% |
| 2024 | $10.24M | +469.7% |
| 2023 | $1.80M | +55.9% |
| 2022 | $1.15M | +3.7% |
| 2022 | $1.11M | -25.1% |
| 2022 | $1.48M | +374.1% |
| 2022 | $313.0K | -49.4% |
| 2021 | $619.0K | -74.6% |
| 2020 | $2.44M | +38.4% |
| 2019 | $1.76M | +382.9% |
| 2018 | $364.5K | -50.1% |
| 2017 | $730.2K | +446.7% |
| 2016 | $133.6K | -12.7% |
| 2015 | $152.9K | -95.7% |
| 2014 | $3.55M | +1845.6% |
| 2013 | $182.3K | +159.2% |
| 2012 | $70.3K | -98.2% |
| 2011 | $3.91M | +836.5% |
| 2010 | $417.5K | -76.6% |
| 2009 | $1.79M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.60M | +194.6% | +13.0% |
| June 30, 2025 | $8.50M | +245.4% | -0.1% |
| March 31, 2025 | $8.50M | +189.5% | -17.0% |
| December 31, 2024 | $10.24M | +469.7% | +214.1% |
| September 30, 2024 | $3.26M | +197.6% | +32.5% |
| June 30, 2024 | $2.46M | +641.0% | -16.2% |
| March 31, 2024 | $2.94M | +2669.8% | +63.4% |
| December 31, 2023 | $1.80M | +55.9% | +64.1% |
- SANUWAVE Health, Inc. showed an increase of +16.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, SANUWAVE Health, Inc.’s cash and equivalents has grown by 569.5% (from $1.79 million to $11.96 million).
- The most recent figure is from SANUWAVE Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: